Indianapolis-based OrthoIndy treated the first patients with Theradaptive’s OsteoAdapt SP spinal fusion implant as part of an ongoing clinical trial.
The Phase I/II Oasis trial is asssing the safety and efficacy of OsteoAdapt SP, an implant made from synthetic material, according to a Nov. 19 news release shared with Becker’s. The implant also has a uniquely designed protein to encourage bone growth.
David Schwartz, MD, performed the first procedure in the clinical trial, and M. Craig McMains, MD, completed the second case.
Aclarion signed a commercial agreement with Spine Institute of Louisiana in Shreveport, according to an April 29 news release. The…
Anthem Blue Cross and Blue Shield established favorable coverage for Mainstay Medical Holdings’ Reactiv8 restorative neurostimulation for intractable chronic low…
New York City-based Spine Associates of NYC has added orthopedic spine surgeon Baron Lonner, MD. Dr. Lonner specializes in scoliosis…
Comments are closed.